-+ 0.00%
-+ 0.00%
-+ 0.00%

Bora Pharmaceuticals Board Approves NTD 143,160 Capital Reduction to Cancel Restricted Shares

PUBT·11/16/2026 07:27:02
Diffusion vocale
Bora Pharmaceuticals Board Approves NTD 143,160 Capital Reduction to Cancel Restricted Shares
  • Bora Pharmaceuticals' board resolved at its Nov. 13, 2026, meeting to reduce capital by NTD 143,160.
  • The reduction cancels 14,316 employee restricted shares following employee resignations under the company's 2025 First Employee Restricted Shares Awards Plan.
  • Share capital will total NTD 1.28 billion following the reduction.
  • The capital reduction record date is Nov. 25, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bora Pharmaceuticals Co. Ltd. published the original content used to generate this news brief on November 16, 2026, and is solely responsible for the information contained therein.